Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1962 Apr;41(4):935–948. doi: 10.1172/JCI104548

PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. III. DEMONSTRATION OF ABNORMAL CLOT STRUCTURE BY ELECTRON MICROSCOPY*

Nils U Bang 1, Anthony P Fletcher 1, Norma Alkjaersig 1, Sol Sherry 1
PMCID: PMC290993  PMID: 13864646

Full text

PDF
940

Images in this article

937Image
on p.937
938Image
on p.938
938Image
on p.938
939Image
on p.939
940Image
on p.940
941Image
on p.941
942Image
on p.942
943Image
on p.943
944Image
on p.944

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. J Clin Invest. 1962 Apr;41:917–934. doi: 10.1172/JCI104547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The activation of human plasminogen. II. A kinetic study of activation with trypsin, urokinase, and streptokinase. J Biol Chem. 1958 Jul;233(1):86–90. [PubMed] [Google Scholar]
  3. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
  5. EDSALL J. T., LEVER W. F. Effects of ions and neutral molecules on fibrin clotting. J Biol Chem. 1951 Aug;191(2):735–756. [PubMed] [Google Scholar]
  6. FLETCHER A. P., ALKJAERSIG N., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J Clin Invest. 1962 Apr;41:896–916. doi: 10.1172/JCI104546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FLETCHER A. P., ALKJAERSIG N., SHERRY S. The maintenance of a sustained thrombolytic state in man. I. Induction and effects. J Clin Invest. 1959 Jul;38(7):1096–1110. doi: 10.1172/JCI103886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HALL C. E., SLAYTER H. S. The fibrinogen molecule: its size, shape, and mode of polymerization. J Biophys Biochem Cytol. 1959 Jan 25;5(1):11–16. doi: 10.1083/jcb.5.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. JOHNSON A. J., FLETCHER A. P., McCARTY W. R., TILLETT W. S. The intravascular use of streptokinase. Ann N Y Acad Sci. 1957 Aug 30;68(1):201–208. doi: 10.1111/j.1749-6632.1957.tb42626.x. [DOI] [PubMed] [Google Scholar]
  10. MORRISON P. R., SCUDDER C. L. Fibrin clot structure during clotting as observed in unsupported films under electron microscope. Am J Physiol. 1952 Jul;170(1):147–154. doi: 10.1152/ajplegacy.1952.170.1.147. [DOI] [PubMed] [Google Scholar]
  11. NIEWIAROWSKI S., KOWALSKI E. Unnouvel anticoagulant dérivé du fibrinogène. Rev Hematol. 1958 Jul-Sep;13(3):320–328. [PubMed] [Google Scholar]
  12. PALADE G. E. A study of fixation for electron microscopy. J Exp Med. 1952 Mar;95(3):285–298. doi: 10.1084/jem.95.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. PORATH J. Fractionation of polypeptides and proteins on dextran gels. Clin Chim Acta. 1959 Nov;4:776–778. doi: 10.1016/0009-8981(59)90026-9. [DOI] [PubMed] [Google Scholar]
  14. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  15. SAWYER W. D., FLETCHER A. P., ALKJAERSIN N., SHERRY S. Studies on the thrombolytic activity of human plasma. J Clin Invest. 1960 Feb;39:426–434. doi: 10.1172/JCI104054. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES